Roxadustat in Kidney Transplant Recipients with ESA-Hyporesponsive Anemia: A Prospective Single-Center Cohort Study

Roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, stimulates erythropoiesis. This prospective single-center, non-randomized, single-arm cohort study enrolled renal transplant recipients with refractory anemia, defined as hemoglobin (Hb) ≤10 g/dL despite receiving the maximum...

全面介紹

書目詳細資料

Principais autores:	Antonio Franco, Patricio Más-Serrano, Iván Beltrá-Picó, Elena de la Cruz, Noelia Balibrea, Nuria Bondia, Javier Perez-Contreras
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2026-05-01
叢編:	Life
主題:	roxadustat refractory anemia renal transplant
在線閱讀:	https://www.mdpi.com/2075-1729/16/5/815
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!